Guanfacine treatment of clozapine-induced sialorrhea [4]

Journal of Clinical Psychopharmacology

Volumn 24, Issue 6, 2004, Pages 675-676

  Webber, Michael A ^a   Szwast, Stanley J ^a   Steadman, Timothy M ^a   Frazer, Amy ^a   Malloy, Frederick W ^a   Lightfoot, Jeffery D ^a   Shekhar, Anantha ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; AMLODIPINE; ATYPICAL ANTIPSYCHOTIC AGENT; CLONIDINE; CLOZAPINE; GUANFACINE; OLANZAPINE; RISPERIDONE; VALPROIC ACID; ZIPRASIDONE;

ADULT; CASE REPORT; DRUG MECHANISM; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; HYPERSALIVATION; LETTER; OPTIMAL DRUG DOSE; PRIORITY JOURNAL; SCHIZOAFFECTIVE PSYCHOSIS; SEDATION; SIDE EFFECT; XEROSTOMIA;

ADULT; CLOZAPINE; FEMALE; GUANFACINE; HUMANS; SIALORRHEA;

EID: 8744276535     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jcp.0000145348.06783.1d     Document Type: Letter

References (20)

1. Davydov L, Botts SR. Clozapine-induced hypersalivation. Ann Pharmacother. 2000;34:662-665.
2. Hinkes R, Quesada TV, Currier MB, et al. Aspiration pneumonia possibly secondary to clozapine-induced sialorrhea [letter]. J Clin Psychopharmacol. 1996;16(6):462-463.
3. Vasile JS, Steingard S. Clozapine and the development of salivary gland swelling: a case study. J Clin Psychiatry. 1995;56:511-513.
4. Chatelut E, Rispail Y, Berlan M, et al. Yohimbine increases human salivary secretion. Br J Clin Pharmacol. 1989;28:366-368.
5. Grabowski J. Clonidine treatment of clozapine-induced hypersalivation. J Clin Psychopharmacol. 1992;12(1):69-70.
6. Oster JR, Epstein M. Use of centrally acting sympatholytic agents in the management of hypertension. Arch Intern Med. 1991;151:1638-1644.
7. Hunt RD, Arnsten AFT, Asbell MD. An open trial of guanfacine in the treatment of attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 1995;34(1): 50-54.
8. Taylor FB, Russo J. Comparing guanfacine and dextroamphetamine for the treatment of adult attention-deficit/hyperactivity disorder. J Clin Psychopharmacol. 2001;21:223-228.
9. Scahill L, Chappell PB, Kim YS, et al. A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder. Am J Psychiatry. 2001;158:1067-1074.
10. Friedman JI, Adler DN, Temporini HD, et al. Guanfacine treatment of cognitive impairment in schizophrenia. Neuropsychopharmacology. 2001;25(3):402-409.
11. Mier RJ, Bachrach SJ, Lakin RC, et al. Treatment of sialorrhea with glycopyrrolate: a double-blind, dose-ranging study. Arch Pediatr Adolesc Med. 2000;154:1214-1218.
12. Bymaster FP, McKinzie DL, Felder CC, et al. Use of M1-M5 muscarinic receptor knockout mice as novel tools to delineate the physiological roles of the muscarinic cholinergic system. Neurochem Res. 2003;28(3/4): 437-442.
13. Zorn SH, Jones SB, Ward KM, et al. Clozapine is a potent and selective muscarinic M4 receptor agonist. Eur J Pharmacol. 1994;269: R1-R2.
14. Bai YM, Lin CC, Chen JY, et al. Therapeutic effect of pirenzepine for clozapine-induced hypersalivation: a randomized, double-blind, placebo-controlled, cross-over study. J Clin Psychopharmacol. 2001;21(6):608-611.
15. Fritze J, Elliger T. Pirenzepine for clozapine-induced hypersalivation. Lancet. 1995;346:1034.
16. Ben-Aryeh H, Jungerman T, Szargel R, et al. Salivary flow-rate and composition in schizophrenic patients on clozapine: subjective reports and laboratory data. Biol Psychiatry. 1996;39:946-949.
17. Rabinowitz T, Frankenburg FR, Centorrino F, et al. The effect of clozapine on saliva flow rate: a pilot study. Biol Psychiatry. 1996;40:1132-1134.
18. McCarthy RH, Terkelsen KG. Esophageal dysfunction in two patients after clozapine treatment. J Clin Psychopharmacol. 1994;14(4):281-283.
19. Bourgeois JA, Drexler KG, Hall MJ. Hypersalivation and clozapine [letter]. Hosp Community Psychiatry. 1991;42(11):1174.
20. Conry A, Siris SG, Bermamzohn PC. Improvement of clozapine-induced sialorrhea after septoplasty. Am J Psychiatry. 1996;153 (3):444.